Tezepelumab (Tezspire)

Status:: Red
Decision Date:: November 2022

Comments

RED: NICE TA880 - for treating severe asthma. (Decision date - May 2023)

Red Drug Classifications

8. NHS England commissioned – to be used in line with NHSE commissioning intentions